Indore: DAVV to hold common entrance test for different courses

Indore: DAVV to hold common entrance test for different courses

The decision was taken at a meeting held on Wednesday. It was decided to remove traditional courses from CET and hold the entrance test only for professional courses.

Staff ReporterUpdated: Thursday, February 20, 2020, 05:54 AM IST
article-image
Devi Ahilya Vishwavidyalaya (DAVV) | Fille pic

Devi Ahilya Vishwavidyalaya (DAVV) on Wednesday decided to hold common entrance test for admission in courses offered by 11 teaching departments.

The departments include School of Law, IMS, EMRC, School of Commerce, School of Social Science, School of Data Sciences, School of Journalism and Mass Communication, School of Economics, School of Computer Science and IIPS and School of Pharmacy.

The decision was taken at a meeting held on Wednesday. It was decided to remove traditional courses from CET and hold the entrance test only for professional courses.

CET committee chairman Ashutosh Mishra said they are in talks with national testing agency and some other software companies for conduct of CET in online mode.

RECENT STORIES

MP Start-Up Summit 2026: 'India Will Soon Become World’s Third Largest Economy,' Says CM Mohan...

MP Start-Up Summit 2026: 'India Will Soon Become World’s Third Largest Economy,' Says CM Mohan...

Indore: Free Press To Host Painting Competition For Students On January 18; Register Now

Indore: Free Press To Host Painting Competition For Students On January 18; Register Now

Indore News: E-Rickshaw Drivers Stage Massive Protest After Transport Dept Restricts Movement In 7...

Indore News: E-Rickshaw Drivers Stage Massive Protest After Transport Dept Restricts Movement In 7...

National Youth Day 2026: Transforming Rural Leadership -- Stories Of Courage & Change

National Youth Day 2026: Transforming Rural Leadership -- Stories Of Courage & Change

Indore Water Tragedy: Death Toll Rises To 23 As 64-Year-Old Dies After 10 Days Of Treatment

Indore Water Tragedy: Death Toll Rises To 23 As 64-Year-Old Dies After 10 Days Of Treatment